Evidence map›Paper›PMID 31601130›Full record

ArticleThe Journal of international medical research2019

Measuring patient activation in Chinese patients with hypertension and/or diabetes: reliability and validity of the PAM13.

Huijuan Zeng, Runsheng Jiang, Mei Zhou, Linxiong Wu, Bo Tian, Yao Zhang, Fanwei Qu

Abstract readValidation Study
In one paragraph

Article in The Journal of international medical research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Measuring patient activation: the utility of the Patient Activation Measure administered in an interview setting.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2024
    Article
  12. Article
  13. Validation of the PAM-13 instrument in the Hungarian general population 40 years old and above.The European journal of health economics : HEPAC : health economics in prevention and care · 2022
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Huijuan ZengSchool of Public Health, Kunming Medical University, Kunming, China.
Runsheng JiangSchool of Public Health, Kunming Medical University, Kunming, China.ORCID https://orcid.org/0000-0001-7509-4484
Mei ZhouSchool of Public Health, Kunming Medical University, Kunming, China.
Linxiong WuSchool of Public Health, Kunming Medical University, Kunming, China.
Bo TianSchool of Public Health, Kunming Medical University, Kunming, China.
Yao ZhangSchool of Public Health, Kunming Medical University, Kunming, China.
Fanwei QuSchool of Public Health, Kunming Medical University, Kunming, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Asian PeoplePatient ParticipationSurveys and QuestionnairesAdultAgedAged, 80 and overChronic DiseaseDiabetes MellitusFactor Analysis, StatisticalFemaleHumansHypertensionMaleMiddle AgedReproducibility of ResultsChinachronic diseasecommunityhypertensionPAM13Patient Activation Measuretype 2 diabetes mellitus

Identifiers

PMID31601130
PMCPMC7045661

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.